The company has recently announced a $300,000 order of its proprietary extract and revealed four years of research and development targeting $170 billion worth of pharmaceutical treatments.
Read More
The primary objective of establishing safety and tolerability was achieved in both healthy adults (study C-001) and in adults with acute otitis media (study C-004).
Read More
Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.
Read More
These changes are the result of Canopy’s intentions to acquire Acreage Holdings, Inc. (“Acreage”) upon U.S. Federal cannabis legalization.
Read More
The reason for the delay is that the Company has not completed its annual audited financial statements because it has not finalized certain entries, none of which is material to the Company’s financial condition.
Read More
Get stock alerts, news & related alerts straight to your inbox!